United States· US:50090-6414_23c59a01-2db9-474a-b262-eed752dc8470
Levemir
A insulin detemir product containing insulin detemir, registered in United States by A-S Medication Solutions. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Insulin detemir is registered in 14 of 19 countries.
Countries holding a registration under ATC A10AE05 (insulin detemir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Insulin detemir · ATC A10AE05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INSULIN DETEMIR
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- A10AE05
- ATC class
- Insulin detemir
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 2
- ndc1150090641405 SYRINGE, PLASTIC in 1 CARTON (50090-6414-0) / 3 mL in 1 SYRINGE, PLASTIC
- ndc1150090-6414-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for insulin detemir.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin detemir · interactions on record
434 records
- 15 severe
- 368 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Insulin detemir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLEVEMIR FLEXPENNovo Nordisk A/S, Bagsvaerd
- United KingdomLevemir FlexPen 100units/ml solution for injection 3ml pre-filled pensMawdsley-Brooks & Company Ltd
- FinlandLevemir FlexpenNovo Nordisk A/S
- BelgiumLevemir 100 U/mlNovo Nordisk
- IcelandLevemir FlexpenNovo Nordisk A/S*
- NetherlandsLevemir Flexpen 100 eenheden/ml oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
- FranceLEVEMIR FLEXPEN 100 Unités/mL, solution injectable en stylo prérempliNOVO NORDISK (DANEMARK)
- SwedenLevemir (FlexPen) 100 E/ml Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Levemir Flexpen, Levemir Flextouch
- Norway · Levemir Flexpen, Levemir Flextouch
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be2cb6de-4898-4d9c-928b-dde45b1367ca GET /v1/drugs/be2cb6de-4898-4d9c-928b-dde45b1367ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "INSULIN DETEMIR",
"productndc": "50090-6414",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "[iU]/mL",
"application_number": "BLA021536",
"marketing_category": "BLA"
}See everything about insulin detemir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.